Inventor · disambiguated record
Marioara Mendelovici
Also filed as: MENDELOVICI MARIOARA
30 granted patents·39 pending applications·305 citations·filing 1999–2009
97Inventor score
Top patents by PatentIndex Score
69 records- 0197US6495721B1Sertraline hydrochloride Form II and methods for the preparation thereofTEVA PHARMA·Filed 2000·Granted Dec 17, 2002·58 cites·22 claims
- 0292US6452054B2Sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and methods of using themTEVA PHARMA·Filed 2000·Granted Sep 17, 2002·36 cites·74 claims
- 0389US7067669B2Substantially pure cilostazol and processes for making sameTEVA PHARMA·Filed 2005·Granted Jun 27, 2006·5 cites·8 claims
- 0488US7064208B2Substantially pure cilostazol and processes for making sameTEVA PHARMA·Filed 2005·Granted Jun 20, 2006·5 cites·9 claims
- 0588US6515128B2Processes for preparing cilostazolTEVA PHARMA·Filed 2001·Granted Feb 4, 2003·20 cites·11 claims
- 0687US6740758B2Processes for preparing 6-hydroxy-3,4-dihydroquinolinone, cilostazol and N-(4-methoxyphenyl)-3-chloropropionamideTEVA PHARMA·Filed 2003·Granted May 25, 2004·13 cites·10 claims
- 0786US7060833B2Substantially pure cilostazol and processing for making sameTEVA PHARMA·Filed 2004·Granted Jun 13, 2006·11 cites·16 claims
- 0886US6841683B2Sulfonation method for zonisamide intermediate in zonisamide synthesis and their novel crystal formsTEVA PHARMA·Filed 2002·Granted Jan 11, 2005·11 cites·8 claims
- 0986US6825214B2Substantially pure cilostazol and processes for making sameTEVA PHARMA·Filed 2003·Granted Nov 30, 2004·11 cites·8 claims
- 1085US6552227B2Process for preparing (+)-cis-sertralineTEVA PHARMA·Filed 2001·Granted Apr 22, 2003·13 cites·30 claims
- 1185US6525201B2Processes for preparing 6-hydroxy-3,4-dihydroquinolinone, cilostazol and N-(4-methoxyphenyl)-3-chloropropionamideTEVA PHARMA·Filed 2001·Granted Feb 25, 2003·11 cites·9 claims
- 1284US6600073B1Methods for preparation of sertraline hydrochloride polymorphsTEVA PHARMA·Filed 2000·Granted Jul 29, 2003·14 cites·29 claims
- 1384US6500987B1Sertraline hydrochloride polymorphsTEVA PHARMA·Filed 1999·Granted Dec 31, 2002·38 cites·89 claims
- 1483US6897340B2Processes for preparation of polymorphic form II of sertraline hydrochlorideTEVA PHARMA·Filed 2003·Granted May 24, 2005·11 cites·39 claims
- 1583US6677458B2Process for the preparation of 1,2-benzisoxazole-3-acetic acidTEVA PHARMA·Filed 2002·Granted Jan 13, 2004·10 cites·16 claims
- 1679US6809221B2Process for preparing (+)-cis-sertralineTEVA PHARMA·Filed 2003·Granted Oct 26, 2004·8 cites·17 claims
- 1778US6660773B2Processes for preparing 6-hydroxy-3,4-dihydroquinolinone, cilostazol and N-(4-methoxyphenyl)3-chloropropionamideTEVA PHARMA·Filed 2002·Granted Dec 9, 2003·6 cites·41 claims
- 1875US6967209B2Processes for preparing 6-hydroxy-3,4-dihydroquinolinone, cilostazol and N-(4-methoxyphenyl)-3-chloropropionamideTEVA PHARMA·Filed 2003·Granted Nov 22, 2005·4 cites·2 claims
- 1974US6858652B2Sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and methods of using themTEVA PHARMA·Filed 2002·Granted Feb 22, 2005·5 cites·14 claims
- 2072US7022881B2Sertraline hydrochloride polymorphsTEVA PHARMA·Filed 2004·Granted Apr 4, 2006·3 cites·6 claims
- 2172US2008091020A1Polymorphic forms of ziprasidone HCI and processes for their preparationTEVA PHARMA·Filed 2007·Application pending·0 cites
- 2269US7129358B2Processes for the production of substituted 2-(2-pyridylmethyl) sulfinyl-1H-benzimidazolesTEVA PHARMA·Filed 2002·Granted Oct 31, 2006·3 cites·7 claims
- 2366US2008287550A1Sertraline hydrochloride form II and methods for the preparation thereofTEVA PHARMA·Filed 2008·Application pending·0 cites
- 2466US2010029943A1Methods for preparing eszopiclone crystalline form a, substantially pure eszopiclone and optically enriched eszopicloneTEVA PHARMA·Filed 2009·Application pending·0 cites
- 2565US7262327B2Recycling process for preparing sertralineTEVA PHARMA·Filed 2004·Granted Aug 28, 2007·3 cites·50 claims
- 2665US2008176949A1Sertraline hydrochloride polymorphsTEVA PHARMA·Filed 2008·Application pending·0 cites
- 2765US2008090835A1Polymorphic forms of ziprasidone HCl and processes for their preparationTEVA PHARMACEUTICALS USA INC F·Filed 2007·Application pending·0 cites
- 2864US6936720B2Method for preparing benzisoxazole methane sulfonyl chloride and its amidation to form zonisamideTEVA PHARMA·Filed 2003·Granted Aug 30, 2005·3 cites·85 claims
- 2963US7667037B2Processes for preparation of ziprasidoneTEVA PHARMA·Filed 2004·Granted Feb 23, 2010·2 cites·37 claims
- 3063US2008091017A1Polymorphic form B2 of ziprasidone baseTEVA PHARMA·Filed 2007·Application pending·0 cites
- 3162US7196222B2Sertraline hydrochloride form II and methods for the preparation thereofTEVA PHARMA·Filed 2004·Granted Mar 27, 2007·1 cites·6 claims
- 3262US2009076272A1Polymorphs of eszopiclone malateTEVA PHARMA·Filed 2008·Application pending·0 cites
- 3361US7319171B2Sertraline hydrochloride form II and methods for the preparation thereofTEVA PHARMA·Filed 2006·Granted Jan 15, 2008·0 cites·16 claims
- 3460US2007093557A1Sertraline hydrochloride form II and methods for the preparation thereofTEVA PHARMA·Filed 2006·Application pending·0 cites
- 3560US2006241189A1Sertraline hydrochloride polymorphsTEVA PHARMA·Filed 2006·Application pending·0 cites
- 3659US2008091024A1Processes for the production of substituted 2-(2-pyridylmethyl) sulfinyl-1H-benzimidazolesTEVA PHARMA·Filed 2007·Application pending·0 cites
- 3759US2007270590A1Methods for preparing eszopiclone crystalline form a, substantially pure eszopiclone and optically enriched eszopicloneMENDELOVICI MARIOARA·Filed 2007·Application pending·0 cites
- 3859US2008091018A1Polymorphic form B2 of ziprasidone baseTEVA PHARMA·Filed 2007·Application pending·0 cites
- 3959US2006069267A1Novel sulfonation method for zonisamide intermediate in zonisamide synthesis and their novel crystal formsNIDAM TAMAR·Filed 2005·Application pending·0 cites
- 4059US2007238738A1Crystalline ziprasidone HCI and processes for preparation thereofTEVA PHARMA·Filed 2007·Application pending·0 cites
- 4159US2008027223A1Polymorphs of eszopiclone malateTEVA PHARMA·Filed 2007·Application pending·0 cites
- 4259US2006063936A1Novel sulfonation method for zonisamide intermediate in zonisamide synthesis and their novel crystal formsNIDAM TAMAR·Filed 2005·Application pending·0 cites
- 4359US2008161607A1Processes for preparation of polymorphic form II of sertraline hydrochlorideTEVA PHARMA·Filed 2008·Application pending·0 cites
- 4459US2008091019A1Polymorphic form B2 of Ziprasidone baseTEVA PHARMA·Filed 2007·Application pending·0 cites
- 4557US2006293363A1Processes for the production of substituted 2-(2-pyridylmethyl) sulfinyl-1H-benzimidazolesTEVA PHARMACEUTICALS USA INC F·Filed 2006·Application pending·0 cites
- 4657US2008214566A1Amorphous ziprasidone mesylateARONHIME JUDITH·Filed 2008·Application pending·0 cites
- 4756US2007032511A1Amorphous ziprasidone mesylateARONHIME JUDITH·Filed 2006·Application pending·0 cites
- 4856US2007213404A1Processes for preparation of polymorphic form II of sertraline hydrochlorideTEVA PHARMACEUTICAL USA INC·Filed 2007·Application pending·0 cites
- 4955US7518018B2Processes for preparing sertralineTEVA PHARMA·Filed 2008·Granted Apr 14, 2009·0 cites·1 claims
- 5055US2005027126A1Processes for preparing zonisamide intermediates and novel crystalline forms of zonisamide intermediatesFiled 2004·Application pending·0 cites
Showing the top 50 of 69 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Marioara Mendelovici files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →